fashion -WSS

fashion

author：focus 2025-09-03 09:37:57 - browse：824

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Midwives could help bridge maternal health disparities in the U.S.

WSS

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

FDA panel to weigh safety of artificial wombs for preterm births

Physician assistants need a new name. Here's what it should be

Merck to acquire Harpoon Therapeutics for $680 million

Merck to acquire Harpoon Therapeutics for $680 million

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

hotspot

fashion

hotspot

Continuity nursing helped my family in our darkest PICU moments

PBMs drew scrutiny in House hearing — and so did pharma

BioMarin wins approval for gene therapy to treat hemophilia A

People with substance use disorder deserve online privacy

DIEP, the 'gold standard' of breast reconstruction, is under threat

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Psychedelics group wrestles with new pharma identity

Life science postdocs should get big pay hike, NIH panel says

Hollywood unions extend contract negotiations for actors

Hospital chaplains balance Covid safety with patients’ spiritual needs

leisure time

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Transgender sports debate: Physicians say bans are health issue

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

White House Covid adviser calls on docs to combat misinformation

Medicare Advantage overpayments discussion gets experts fired up

Fauci's latest grilling in Congress: 9 hours, behind closed doors

leisure time

explore

entertainment

entertainment